These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6801811)

  • 1. The 'in vivo' survival characteristics of factor VIII procoagulant antigen (VIII:C Ag) in haemophilia A subjects.
    McLellan DS; Pelly C; McLellan HG; Jones P; Aronstam A
    Thromb Res; 1982 Jan 1-15; 25(1-2):33-9. PubMed ID: 6801811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII:C and VIII:CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma.
    Holmberg L; Borge L; Nilsson IM
    Br J Haematol; 1981 Apr; 47(4):587-96. PubMed ID: 6783063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII procoagulant antigen recovery is a dose-related response to Factor VIII concentrate infusions.
    Taylor L; Ekert H; Dean F
    Haemostasis; 1984; 14(4):296-301. PubMed ID: 6437942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoradiometric assay of procoagulant factor VIII antigen (VIIICAG).
    Muller HP; van Tilburg NH; Bertina RM; Terwiel JP; Veltkamp JJ
    Clin Chim Acta; 1980 Oct; 107(1-2):11-9. PubMed ID: 6775848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radial immunodiffusion method for the assay of factor VIII:C Antigen (VIII:C Ag) in plasma.
    McLellan DS; Devlin JD; Groom P; Aronstam A
    Br J Haematol; 1981 Feb; 47(2):295-305. PubMed ID: 6781528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of D.D.A.V.P. on the survival of factor VIII in severe haemophiliacs.
    McLellan DS; Knight S; McLellan HG; Wassef M; Aronstam A
    Thromb Res; 1985 Oct; 40(1):113-9. PubMed ID: 3937282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease.
    Tuddenham EG; Lane RS; Rotblat F; Johnson AJ; Snape TJ; Middleton S; Kernoff PB
    Br J Haematol; 1982 Oct; 52(2):259-67. PubMed ID: 6812613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of factor VIII procoagulant antigen in normal subjects and in hemophilia A patients by an immunoradiometric assay and by an enzyme-linked immunosorbent assay.
    Hellstern P; Miyashita C; Köhler M; von Blohn G; Kiehl R; Biro G; Schwerdt H; Wenzel E
    Haemostasis; 1987; 17(4):173-81. PubMed ID: 3114101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stability of VIII:C in frozen stored plasma samples--re-examined.
    McLellan DS; Pelly C; McLellan HG; Aronstam A
    Clin Lab Haematol; 1983; 5(2):197-201. PubMed ID: 6411419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B; Ratnoff OD
    J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procoagulant specificity of factor VIII inhibitor.
    Yang HC; Kuzur M
    Br J Haematol; 1977 Nov; 37(3):429-33. PubMed ID: 304738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII clotting antigen (VIIICAg) in haemophilia measured by two immunoradiometric assays (IRMA) using different antibodies, and the measurement of inhibitors to procoagulant factor VIII (VIIIC) by IRMA.
    Furlong RA; Peake IR; Bloom AL
    Br J Haematol; 1981 Aug; 48(4):643-50. PubMed ID: 6791678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of haemophilia A: a study with three different antisera.
    Muller HP; van Tilburg NH; Bertina RM; Veltkamp JJ
    Br J Haematol; 1982 Nov; 52(3):485-94. PubMed ID: 6812615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoradiometric measurement of the factor VIII procoagulant antigen.
    Lazarchick J; Hoyer LW
    J Clin Invest; 1978 Nov; 62(5):1048-52. PubMed ID: 81838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the value of factor VIII procoagulant and antigen ratio in the diagnosis of carriers of haemophilia.
    D'Souza S; Ekert H; Ananthakrishnan R; Muntz RH
    Aust N Z J Med; 1976 Jun; 6(3):218-22. PubMed ID: 1067820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor viii-related antigen in the detection of the haemophilia carrier state.
    Gomperts ED; Whitbread P; Feesey M
    S Afr Med J; 1975 Jun; 49(25):1005-7. PubMed ID: 1154143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enzyme immunoassay (ELISA) for the quantitation of human factor VIII coagulant antigen (VIII:CAg).
    Dinesen B; Feddersen C
    Thromb Res; 1983 Sep; 31(5):707-18. PubMed ID: 6417826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of factors VIII:C and VIIIR:Ag in the detection of classic hemophilia. Study of 40 cases].
    Ambríz-Fernández R; Reyna-Fregoso MP; Cruz ML; Avilés A; García MA; Morales MR; Pizzuto J
    Rev Invest Clin; 1984; 36(3):257-63. PubMed ID: 6440253
    [No Abstract]   [Full Text] [Related]  

  • 20. An in vivo study of a new factor VIII high purity preparation.
    Thorell L; Blombäck M; Blombäck B
    Thromb Res; 1983 Jul; 31(2):375-85. PubMed ID: 6415854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.